Phio Pharmaceuticals (PHIO) Director Patricia A. Bradford Buys 12,000 Shares

What Happened Patricia A. Bradford, a director of Phio Pharmaceuticals Corp. (PHIO), reported an open-market purchase of 12,000 shares on 2026-09-15 at $1.03 per share, for a total reported cash outlay of $12,360. This filing shows an acquisition (transaction code P), which is a direct purchase rather than a sale or option exercise.

Key Details

• Transaction date: 2026-09-15; Filing date: 2026-09-16 (filed promptly).
• Price per share: $1.03; Shares acquired: 12,000; Total value: $12,360.
• Shares owned after transaction: Not specified in the filing.
• Footnote F1: The reported holdings include shares underlying unvested restricted stock units (RSUs), meaning some included shares may not be freely tradable yet.
• Transaction type: P = Purchase (open-market/private purchase as reported).

Context

• Purchases by insiders can draw attention from retail investors as one data point of insider conviction, but they do not by themselves prove future performance.
• Because the filing notes inclusion of unvested RSUs (F1), the reported holdings may reflect restricted units that vest later rather than only immediately tradable shares.